Literature DB >> 14764364

Meperidine analgesia and delirium in aged hip fracture patients.

Abraham Adunsky1, Rami Levy, Michael Heim, Eliyahu Mizrahi, M Arad.   

Abstract

Delirium is quite frequent in elderly patients who sustain hip fractures. The use of Meperidine by physicians, unaware of the possible emergence of delirium in elderly patients, is very popular. We have retrospectively examined the incidence of delirium in 181 consecutive patients admitted to the orthogeriatric ward with hip fractures. We used the confusion assessment method to establish the presence of delirium in all patients. A database search was conducted to identify which patients were treated by Meperidine, or Morphine, prior to delirium onset. We identified 92 cases, 44 of whom were treated by Meperidine alone, and the other 48 treated by Morphine alone. Delirium was diagnosed in 13 (27.1%) Morphine treated patients as compared with 19 (43.2%) treated by Meperidine (P<0.001). Age, cognitive status and opiate use were associated with perioperative delirium. A subset regression analysis showed that exposure to Meperidine was significantly associated with delirium (odds ratio 2.5, P<0.01), in contrast with Morphine. Our results confirm the association between exposure to Meperidine and delirium, suggesting that this drug should be withdrawn in elderly hip fractured patients undergoing surgery, and substituted by low dose Morphine analgesia. Reducing the incidence of delirium, by adopting such an approach, may result in a significant potential of savings in direct costs, related to treatment of delirium in this population.

Entities:  

Year:  2002        PMID: 14764364     DOI: 10.1016/s0167-4943(02)00045-6

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  9 in total

1.  Inappropriate medication use in older adults undergoing surgery: a national study.

Authors:  Emily Finlayson; Judith Maselli; Michael A Steinman; Michael B Rothberg; Peter K Lindenauer; Andrew D Auerbach
Journal:  J Am Geriatr Soc       Date:  2011-08-30       Impact factor: 5.562

Review 2.  Delirium in the older emergency department patient: a quiet epidemic.

Authors:  Jin H Han; Amanda Wilson; E Wesley Ely
Journal:  Emerg Med Clin North Am       Date:  2010-08       Impact factor: 2.264

Review 3.  The Challenges of Anaesthesia and Pain Relief in Hip Fracture Care.

Authors:  Rachel Cowan; Jun Hao Lim; Terence Ong; Ashok Kumar; Opinder Sahota
Journal:  Drugs Aging       Date:  2017-01       Impact factor: 3.923

4.  Probable risk factors for postoperative delirium in patients undergoing spinal surgery.

Authors:  Rui Gao; Zhi-Zhou Yang; Ming Li; Zhi-Cai Shi; Qiang Fu
Journal:  Eur Spine J       Date:  2008-09-16       Impact factor: 3.134

Review 5.  Altered mental status in older patients in the emergency department.

Authors:  Jin H Han; Scott T Wilber
Journal:  Clin Geriatr Med       Date:  2013-02       Impact factor: 3.076

6.  Pharmacological risk factors for delirium after cardiac surgery: a review.

Authors:  Lurdes Tse; Stephan Kw Schwarz; John B Bowering; Randell L Moore; Kyle D Burns; Carole M Richford; Jill A Osborn; Alasdair M Barr
Journal:  Curr Neuropharmacol       Date:  2012-09       Impact factor: 7.363

7.  Comparison of regional with general anaesthesia on postoperative delirium (RAGA-delirium) in the older patients undergoing hip fracture surgery: study protocol for a multicentre randomised controlled trial.

Authors:  Ting Li; Joyce Yeung; Jun Li; Yan Zhang; Teresa Melody; Ye Gao; Yi Wang; Qianquan Lian; Fang Gao
Journal:  BMJ Open       Date:  2017-10-22       Impact factor: 2.692

Review 8.  The Comparative Risk of Delirium with Different Opioids: A Systematic Review.

Authors:  Lieke M Swart; Vera van der Zanden; Petra E Spies; Sophia E de Rooij; Barbara C van Munster
Journal:  Drugs Aging       Date:  2017-06       Impact factor: 3.923

Review 9.  Antipsychotic Drugs in Prevention of Postoperative Delirium-What Is Known in 2020?

Authors:  Michał P Pluta; Magdalena Dziech; Piotr F Czempik; Anna J Szczepańska; Łukasz J Krzych
Journal:  Int J Environ Res Public Health       Date:  2020-08-20       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.